XML 56 R44.htm IDEA: XBRL DOCUMENT v3.25.0.1
Additional Financial Information (Tables)
9 Months Ended
Dec. 31, 2024
Additional Financial Information [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported in the unaudited condensed consolidated balance sheets to the total amounts reported in the unaudited condensed consolidated statements of cash flows at December 31, 2024 and March 31, 2024. At December 31, 2024 and March 31, 2024, restricted cash represents primarily amounts related to required cash reserves for interest payments associated with certain corporate debt and film related obligations.
December 31,
2024
March 31,
2024
 (Amounts in millions)
Cash and cash equivalents$200.5 $314.0 
Restricted cash included in other current assets42.8 43.7 
Restricted cash included in other non-current assets10.8 13.7 
Total cash, cash equivalents and restricted cash$254.1 $371.4 
Schedule of Other Assets
The composition of the Company’s other assets is as follows as of December 31, 2024 and March 31, 2024:
 
December 31,
2024
March 31,
2024
 (Amounts in millions)
Other current assets
Prepaid expenses and other$54.4 $58.2 
Restricted cash42.8 43.7 
Contract assets72.5 59.9 
Interest rate swap assets— 35.6 
Tax credits receivable140.7 199.1 
$310.4 $396.5 
Other non-current assets
Prepaid expenses and other$18.6 $21.6 
Restricted cash10.8 13.7 
Accounts receivable48.0 111.7 
Contract assets10.3 3.2 
Tax credits receivable440.6 361.7 
Operating lease right-of-use assets338.6 388.8 
Interest rate swap assets0.7 — 
$867.6 $900.7 
Summary of Receivables Transferred The following table sets forth a summary of the receivables transferred under individual agreements or purchases during the three and nine months ended December 31, 2024 and 2023:
Three Months EndedNine Months Ended
December 31,December 31,
2024202320242023
 (Amounts in millions)
Carrying value of receivables transferred and derecognized$258.0 $305.9 $963.3 $1,065.9 
Net cash proceeds received254.5 300.7 948.1 1,045.6 
Loss recorded related to transfers of receivables3.5 5.2 15.2 20.3 
The following table sets forth a summary of the receivables transferred under the pooled monetization agreement during the nine months ended December 31, 2023:
Nine Months Ended
December 31,
2023
 (Amounts in millions)
Gross cash proceeds received for receivables transferred and derecognized$22.2 
Less amounts from collections reinvested under revolving agreement(9.1)
Proceeds from new transfers13.1 
Collections not reinvested and remitted or to be remitted(13.4)
Net cash proceeds received (paid or to be paid)(1)
$(0.3)
Carrying value of receivables transferred and derecognized (2)
$22.1 
Obligations recorded$2.1 
Loss recorded related to transfers of receivables$2.0 
___________________
(1)During the three and nine months ended December 31, 2023, the Company voluntarily repurchased $46.0 million of receivables previously transferred.
(2)Receivables net of unamortized discounts on long-term, non-interest bearing receivables.
Schedule of Accumulated Other Comprehensive Income
The following table summarizes the changes in the components of accumulated other comprehensive income, net of tax. During the nine months ended December 31, 2024 and 2023, there was no income tax expense or benefit reflected in other comprehensive income due to the income tax impact being offset by changes in the Company’s deferred tax valuation allowance.
Foreign currency translation adjustmentsNet unrealized gain (loss) on cash flow hedgesTotal
(Amounts in millions)
March 31, 2024$(22.7)$138.7 $116.0 
Other comprehensive income (loss)(11.3)4.4 (6.9)
Reclassifications to net loss(1)
— (21.4)(21.4)
Reclassifications to noncontrolling interest(2)
5.3 (16.6)(11.3)
December 31, 2024$(28.7)$105.1 $76.4 
March 31, 2023$(21.6)$142.5 $120.9 
Other comprehensive income (loss)1.6 17.4 19.0 
Reclassifications to net loss(1)
— (23.5)(23.5)
December 31, 2023$(20.0)$136.4 $116.4 
___________________
(1)Represents a loss of $1.2 million included in direct operating expense and a gain of $22.6 million included in interest expense on the unaudited condensed consolidated statement of operations in the nine months ended December 31, 2024 (nine months ended December 31, 2023 - loss of $2.5 million included in direct operating expense and a gain of $26.0 million included in interest expense) (see Note 17).
(2)Represents amounts reclassified in connection with the noncontrolling interest recorded for the proportionate ownership interest in the carrying value of Lionsgate Studios (see Note 2).